FDA Approves Ibsrela (tenapanor) for the Treatment of Irritable Bowel Syndrome with Constipation

Print this page FREMONT, Calif., Sept. 12, 2019 /PRNewswire/ — Ardelyx, Inc. today announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a 50 mg, twice daily oral pill for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. Ibsrela is a minimally-absorbed small molecule that acts locally in the… Read More »

Women in medicine are trailblazers, advocates, and leaders

A guest column by the American Medical Association, exclusive to KevinMD.com. Each September, the American Medical Association (AMA) is proud to recognize and honor the immense contributions women make to the House of Medicine. Such recognition is particularly appropriate this year. I count myself lucky to be joined by two exceptional women physicians in holding the offices… Read More »